Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3129949 | Dental Cadmos | 2014 | 21 Pages |
Abstract
The management of dentin hypersensitivity is based on the control of causal factors and on the application, at-home or in-office, of various products aimed to occlude patent tubules. In vitro methods suffer from some limitations in mimicking “real-life” individual behaviours and ecological variables in the oral environment, therefore randomized and controlled clinical trials are considered the gold standard to evaluate the efficacy of these products. The arginine-calcium carbonate complex has proved to be efficacious in providing instant and long-lasting relief. Further randomized and controlled clinical studies are needed to confirm the results of amorphous sodium calcium phosphosilicate and strontium acetate.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
F. Cruciata, G. Pizzo,